The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 23, 2022

Filed:

Dec. 29, 2017
Applicants:

Laxxon Medical Ag, Stetten, CH;

Exentis Knowledge Gmbh, Stetten, CH;

Inventors:

Achim Schneeberger, Vienna, AT;

Klaus Kühne, Berlin, DE;

Helmut Kerschbaumer, Zürich, CH;

Srdan Vasic, Horgen, CH;

Assignees:

Laxxon Medical AG, Stetten, CH;

Exentis Knowledge GmbH, Stetten, CH;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/20 (2006.01); A61K 31/496 (2006.01); A61K 31/4468 (2006.01); A61K 31/5377 (2006.01); A61K 31/519 (2006.01); A61K 31/4985 (2006.01); A61K 31/506 (2006.01); A61K 31/422 (2006.01); A61K 31/44 (2006.01); A61K 31/4439 (2006.01); A61K 31/7072 (2006.01);
U.S. Cl.
CPC ...
A61K 9/2077 (2013.01); A61K 9/2027 (2013.01); A61K 9/2054 (2013.01); A61K 9/2059 (2013.01); A61K 31/422 (2013.01); A61K 31/44 (2013.01); A61K 31/4439 (2013.01); A61K 31/4468 (2013.01); A61K 31/496 (2013.01); A61K 31/4985 (2013.01); A61K 31/506 (2013.01); A61K 31/519 (2013.01); A61K 31/5377 (2013.01); A61K 31/7072 (2013.01);
Abstract

The present invention relates to a drug delivery system, in particular for a controlled administration of one or more active pharmaceutical ingredients to a body, and further in particular for oral administration of one or more active pharmaceutical ingredients to a body. The system thereby comprises a base component soluble in body fluids and a separate first component soluble in body fluids. The first component thereby comprises a therapeutically effective amount of a first active pharmaceutical ingredient.


Find Patent Forward Citations

Loading…